Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.
Wang Z, Lu Y, Liu Y, Mou J, Liu X, Chen M, Wang Y, Xu Y, Rao Q, Xing H, Tang K, Tian Z, Wang B, Qi W, Wang M, Qiu S, Xiong D, Wang J.
Wang Z, et al. Among authors: wang j, wang y, wang m, wang b.
Cancer Commun (Lond). 2023 Oct;43(10):1178-1182. doi: 10.1002/cac2.12474. Epub 2023 Jul 31.
Cancer Commun (Lond). 2023.
PMID: 37525513
Free PMC article.
No abstract available.